Ignite Creation Date:
2025-12-24 @ 11:48 PM
Ignite Modification Date:
2025-12-26 @ 4:50 PM
Study NCT ID:
NCT01171651
Status:
COMPLETED
Last Update Posted:
2016-01-20
First Post:
2010-07-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Recombinant Vaccinia Virus Prior to Sorafenib to Treat Unresectable Primary Hepatocellular Carcinoma
Sponsor:
Jennerex Biotherapeutics
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
JX594-HEP016
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None